An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults
Clinical trial NCT07467707 · RECRUITING
Trial details
- NCT number
- NCT07467707
- Sponsor
- Bavarian Nordic
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-26
- Primary completion
- 2030-05-01
- Enrollment
- 6144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.